Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs

Completed · Phase 4

Conditions studied: Diabetes, Diabetes Mellitus, Type 2

In brief

This trial is conducted in the United States of America (USA). The aim of this trial is to investigate the effectiveness of biphasic insulin aspart 30 in type 2 diabetics not achieving blood sugar levels when treated with oral anti-diabetics drugs (OADs) with or without basal insulin therapy.

Key facts

Study ID

NCT00791895

Run by

Novo Nordisk A/S

People needed

102

Starts

2003-06-26

Expected to finish

2004-11-29

Last updated by the study team

2017-02-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Type 2 diabetes mellitus for at least 12 months
• HbA1c: 7.5-10.0%
• An antidiabetic regimen that has been stable for at least 3 months
• Able and willing to perform SMBG testing as per protocol

You may not qualify if…

• Use of any insulin preparations other than NPH or glargine within the past 6 months
• Pregnancy, breastfeeding, intention to become pregnant within the next 12 months, or judged to be using inadequate contraceptive measures (adequate contraceptive measures includes: sterilization, intrauterine devices, oral contraceptives, or consistent use of barrier methods)
• Known or suspected allergy to trial product or agents related to trial product

Where it is running

• Novo Nordisk Investigational Site — Phoenix, Arizona, United States
• Novo Nordisk Investigational Site — La Jolla, California, United States
• Novo Nordisk Investigational Site — La Jolla, California, United States
• Novo Nordisk Investigational Site — DeLand, Florida, United States
• Novo Nordisk Investigational Site — Wichita, Kansas, United States
• Novo Nordisk Investigational Site — Omaha, Nebraska, United States
• Novo Nordisk Investigational Site — Albany, New York, United States
• Novo Nordisk Investigational Site — Cleveland, Ohio, United States
• Novo Nordisk Investigational Site — Medford, Oregon, United States
• Novo Nordisk Investigational Site — Memphis, Tennessee, United States
• Novo Nordisk Investigational Site — Dallas, Texas, United States
• Novo Nordisk Investigational Site — Houston, Texas, United States
• Novo Nordisk Investigational Site — Ogden, Utah, United States
• Novo Nordisk Investigational Site — Renton, Washington, United States
• Novo Nordisk Investigational Site — Milwaukee, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.